Canopy Growth provides update on international operations and activities

SMITHS FALLS, ON , June 17, 2019 /CNW/ – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (WEED.TO)(CGC) is pleased to highlight recent developments that are fueling its international progress in emerging medical cannabis and CBD markets. The Company’s global three-prong strategy includes a focus on building best-in-class global GMP (Good Manufacturing Practices) infrastructure, advancing clinical research programs and best-in-class education and sales programs through its Spectrum Therapeutics medical division, and launching CBD products where regulatory environments allow.

READ MORE: https://finance.yahoo.com/news/canopy-growth-provides-international-operations-120000117.html?.tsrc=rss